Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments.

brain metastasis genetic mutations metachronous neurosurgery precocious radiosurgery synchronous

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
03 Dec 2020
Historique:
received: 04 11 2020
revised: 26 11 2020
accepted: 28 11 2020
entrez: 8 12 2020
pubmed: 9 12 2020
medline: 9 12 2020
Statut: epublish

Résumé

We attempted to analyze whether early presentation with brain metastases (BM) represents a poor prognostic factor in patients with non-small cell lung cancer (NSCLC), which should guide the treatment team towards less intensified therapy. In a retrospective bi-centric analysis, we identified patients receiving surgical treatment for NSCLC BM. We collected demographic-, tumor-, and treatment-related parameters and analyzed their influence on further survival. We included 377 patients. Development of BM was precocious in 99 (26.3%), synchronous in 152 (40.3%), and metachronous in 126 (33.4%) patients. The groups were comparable in terms of age ( Early BM presentation was not associated with worse OS in NSCLC BM patients.

Identifiants

pubmed: 33287226
pii: cancers12123618
doi: 10.3390/cancers12123618
pmc: PMC7761690
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Neurosurg. 2000 Dec;93(6):927-31
pubmed: 11117864
Eur J Cardiothorac Surg. 2004 Jun;25(6):1107-13
pubmed: 15145017
Eur J Cancer. 2015 Nov;51(17):2508-16
pubmed: 26277099
Nat Genet. 2012 Oct;44(10):1104-10
pubmed: 22941188
J Neurosurg. 1995 Oct;83(4):605-16
pubmed: 7674008
J Thorac Cardiovasc Surg. 1996 Jul;112(1):146-53
pubmed: 8691861
J Neurol Surg A Cent Eur Neurosurg. 2018 Mar;79(2):101-107
pubmed: 28586934
JAMA Oncol. 2019 Feb 1;5(2):243-247
pubmed: 30419088
J Cancer Res Clin Oncol. 2013 Mar;139(3):403-8
pubmed: 23124140
Clin Cancer Res. 2019 Nov 15;25(22):6570-6580
pubmed: 31213459
Eur J Cardiothorac Surg. 2001 Aug;20(2):361-6
pubmed: 11463558
Cancer. 2019 Oct 15;125(20):3535-3544
pubmed: 31287555
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):510-4
pubmed: 17931798
Eur J Cancer. 2011 Mar;47(5):649-55
pubmed: 21196112
J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53
pubmed: 11547308
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
pubmed: 9128946
Handb Clin Neurol. 2018;149:3-23
pubmed: 29307359
J Neurooncol. 2011 Jul;103(3):649-55
pubmed: 20978821
Clin Exp Metastasis. 2018 Dec;35(8):727-738
pubmed: 30421093
N Engl J Med. 2017 Aug 31;377(9):829-838
pubmed: 28586279
Mod Pathol. 2019 May;32(5):627-638
pubmed: 30459450
J Clin Oncol. 2015 Oct 20;33(30):3475-84
pubmed: 26282648
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1001-6
pubmed: 10863071
World Neurosurg. 2018 May;113:e1-e9
pubmed: 29104152
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Am Soc Clin Oncol Educ Book. 2019 Jan;39:e59-e69
pubmed: 31099629
Anticancer Res. 2012 Nov;32(11):4655-62
pubmed: 23155227

Auteurs

Stephanie T Jünger (ST)

Centre for Neurosurgery, Department of Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.
Centre for Integrated Oncology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Petra Schödel (P)

Department of Neurosurgery, University Medical Centre Regensburg, 93053 Regensburg, Germany.
Wilhelm Sander Neuro-Oncology Unit, University Medical Centre Regensburg, 93053 Regensburg, Germany.

Daniel Ruess (D)

Centre for Integrated Oncology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.
Centre for Neurosurgery, Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Maximilian Ruge (M)

Centre for Integrated Oncology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.
Centre for Neurosurgery, Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Julia-Sarita Brand (JS)

Centre for Neurosurgery, Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Maike Wittersheim (M)

Department of Pathology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Marie-Lisa Eich (ML)

Department of Pathology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Nils-Ole Schmidt (NO)

Department of Neurosurgery, University Medical Centre Regensburg, 93053 Regensburg, Germany.
Wilhelm Sander Neuro-Oncology Unit, University Medical Centre Regensburg, 93053 Regensburg, Germany.

Roland Goldbrunner (R)

Centre for Neurosurgery, Department of Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.
Centre for Integrated Oncology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Stefan Grau (S)

Centre for Neurosurgery, Department of Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.
Centre for Integrated Oncology, Faculty of Medicine and University Hospital, University of Cologne, 50931 Cologne, Germany.

Martin Proescholdt (M)

Department of Neurosurgery, University Medical Centre Regensburg, 93053 Regensburg, Germany.
Wilhelm Sander Neuro-Oncology Unit, University Medical Centre Regensburg, 93053 Regensburg, Germany.

Classifications MeSH